MedPath

Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS

Completed
Conditions
Multiple Sclerosis
Registration Number
NCT02965170
Lead Sponsor
Rocky Mountain MS Research Group, LLC
Brief Summary

Validating a peptide-based laboratory test enabling the measurement of Tysabri® serum levels (pharmacokinetics, PK) in multiple sclerosis patients undergoing therapy. The results of this newly developed test will be compared to Tysabri® serum levels measured in parallel using an independent test. We will also simultaneously measure a pharmacodynamic marker of Tysabri®, receptor saturation levels on blood immune cells, which is thought to correlate with Tysabri® serum levels.

Detailed Description

From a single site, consenting patients with relapsing forms of multiple sclerosis who are currently begin treated with Tysabri® (natalizumab) and meeting the eligibility criteria will be asked to provide blood samples on the same day, and prior to, a scheduled infusion of Tysabri® 300 mg IV. Up to 500 patients will be enrolled in this study. Each patient may be asked to donate blood up to 2 times (one blood draw per cycle) to obtain longitudinal data points. Each patient will also be asked to fill out a wellness patient reported outcome (PRO) questionnaire along with the blood draws

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
109
Inclusion Criteria
  • Infusing with Tysabri at a single site, Rocky Mountain MS Clinic
Exclusion Criteria
  • If subject donated or received blood, plasma, or any other blood products between the last Tysabri® infusion and the time of sample collection.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Natalizumab Concentrations in Serum12 Months

Validate a novel peptide-based laboratory test enabling the measurement of nadir natalizumab (Tysabri®) serum levels in multiple sclerosis patients undergoing therapy compared to the traditional ELISA assay

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rocky Mountain MS Clinic

🇺🇸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath